To enhance the availability of Remdesivir injection, the antiviral drug used in treating COVID-19, pharmaceutical companies have reduced the price. This was done following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.

Drug companies like Cadila Healthcare, Dr Reddy's Laboratories and Cipla have slashed the prices of their respective brands of Remdesivir injection (100 mg/vial).

 Union Chemicals and Fertilizers Minister Sadananda Gowda hailed the decision taken by the drug companies.

According to the details shared by the NPPA, here are the price changes in the COVID injection.

Earlier a war of words broke out between Mandaviya and NCP leader Nawab Malik on the availability of Remdesivir. The allegations made were strongly refuted by Mandaviya, who said the government is making every effort to double the production of the drug in the country.

Various states and Union Territories in a meeting convened by the Centre to review COVID-19 measures on Saturday called for stepping up the supply of the antiviral injection and oxygen.